acta paediatr scand suppl 301 1982@schweiz med wochenschr@martin aj@marks mi@infant@raeburn-j-a@appeared@am rev respir dis@four@gap conf rep pseudomon in cf@scand j infect dis@kelly hw@respiratory@ad@large@govan jrw@j-infect-dis@j pediatr@hawley hb@arch dis child@wientzen r@postgrad med j@highest@adolescence@fibrosis@obtained@antibiotics@eradicated@fraser gl@s 62 980@warwick wj@wood re@larger@dosage@suppl@treatment@infection@study@doses@weeks@am j dis child@two@chrystyn h@in: apley j@mombelli g@antimicrob agents chemother@levy j@cystic-fibrosis@established@side@huang nn@co@hanson-e-j@curr ther res@horrevorts am@cystic@antibiotic@tu@suffering@acta paediatr scand@hodson me@med j aust@dt@follow-up@mendelman pm@conway sp@in: lawson d proc 5th int cf@infections@treated@given@chest@mccrae wm@am j hosp pharm@kuhn rj@patients@child-preschool@mucoid@thys jp@mccrae-w-m@aug@effects@effect@j clin hosp pharm@riff l@child@pedersen ss@hoiby n@pseudomonas@concentrations@neu hc@aeruginosa@sputum@tobramycin@duration@s191-3@patient@vakoutis j@clin pharmacy@human@successful@therapy@j antimicrob chemother@raeburn ja@concentration@marlin ge@peak@drug intel clin pharm@malmborg as@pseudomonas-infections@noted@conventional@due@short@sem perinatol@br j dis chest@